Necrobiosis Lipodica (NL) Market Report 2026

Necrobiosis Lipodica (NL) Market Overview

• Necrobiosis Lipodica (NL) market size has reached to $4.35 billion in 2025 • Expected to grow to $5.95 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Surge In Diabetes Cases Fueling The Growth Of The Market Due To Increasing Prevalence And Associated Complications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Necrobiosis Lipodica (NL) Market?

Necrobiosis lipoidica is a rare, chronic skin condition characterized by yellowish, atrophic plaques with prominent blood vessels, most commonly affecting the shins. It is associated with collagen degeneration, inflammation, and lipid accumulation in the skin. The main treatment types for necrobiosis lipoidica (NL) include therapy, drugs, and other treatments. Therapy is a treatment intended to relieve or heal a disorder or condition, often involving medical, psychological, or physical interventions. Various routes of administration exist, including oral, topical, parenteral, and other methods. Additionally, the diagnosis of NL involves methods such as skin biopsy, histopathology, and other diagnostic approaches. Treatments are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies. Furthermore, the end users of these treatments include hospitals, home care settings, specialty clinics, and other healthcare providers.

What Is The Necrobiosis Lipodica (NL) Market Growth Forecast?

The necrobiosis lipodica (nl) market size is expected to see strong growth in the next few years. It will grow to $5.95 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growing demand for biologics and immunomodulators, expansion of regenerative medicine solutions, increasing availability of laser and phototherapy devices, rising investment in dermatology clinical research, development of combination therapeutic protocols. Major trends in the forecast period include increasing use of phototherapy and laser-based modalities, rising adoption of advanced wound care and compression therapies, growing preference for topical and systemic immunomodulators, higher focus on early skin biopsy and differential diagnosis, expansion of regenerative medicine applications including stem cell therapy.

Global Necrobiosis Lipodica (NL) Market Segmentation

1) By Treatment: Therapy, Drugs, Other Treatments 2) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administrations 3) By Diagnosis: Skin Biopsy, Histopathology, Other Diagnosis 4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy 5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments: 1) By Therapy: Phototherapy, Laser Therapy, Wound Care And Compression Therapy, Physical Therapy And Rehabilitation 2) By Drugs: Topical Corticosteroids, Intralesional Corticosteroids, Systemic Corticosteroids, Immunomodulators, Biologics, Antiplatelet Agents, Antioxidants And Vasodilators, Antibiotics 3) By Other Treatments: Surgical Excision And Skin Grafting, Hyperbaric Oxygen Therapy (HBOT), Platelet-Rich Plasma (PRP) Therapy, Stem Cell Therapy And Regenerative Medicine, Alternative And Herbal Treatments

What Are The Drivers Of The Necrobiosis Lipodica (NL) Market?

The increasing cases of diabetes are expected to propel the growth of the necrobiosis lipoidica (NL) market going forward. Diabetes is a chronic condition where the body struggles to regulate blood sugar due to insufficient insulin production or resistance, leading to potential health complications. The increase in diabetes cases is due to sedentary lifestyles, unhealthy diets, and genetic predisposition. Modern lifestyles involve prolonged sitting, reduced physical activity, and excessive screen time, leading to obesity and insulin resistance. High blood sugar levels in diabetes cause damage to small blood vessels (microangiopathy), leading to poor circulation. It reduces oxygen and nutrient supply to the skin, making it more vulnerable to injury and delayed healing. The skin tissue degenerates, contributing to the formation of yellowish, atrophic plaques in NL. For instance, in March 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%, the highest value ever reported by the National Diabetes Audit (NDA). Therefore, increasing cases of diabetes are driving the growth of the necrobiosis lipoidica (NL) market. The rising incidence of autoimmune diseases is expected to propel the growth of the necrobiosis lipoidica market going forward. Autoimmune diseases are conditions where the body's immune system mistakenly attacks its healthy cells and tissues. The growing incidence of autoimmune diseases is driven by factors such as genetic predisposition, environmental triggers, and changes in lifestyle and immune system behavior. Autoimmune diseases contribute to necrobiosis lipoidica (NL) by triggering chronic inflammation and immune system dysfunction, leading to collagen degeneration and impaired skin healing. For instance, in September 2025, according to WeCovr, a UK-based insurance comparison platform, it is projected that more than 3.5 million people in the United Kingdom will be living with an autoimmune disease by the close of 2025. Therefore, the higher incidence of autoimmune diseases is driving the growth of the necrobiosis lipoidica market. The growing demand for personalized medicine is expected to propel the growth of the necrobiosis lipoidica (NL) market going forward. Personalized medicine refers to an individualized approach to healthcare in which diagnostic insights, molecular characteristics, and patient-specific clinical factors guide the selection of tailored therapeutic strategies to optimize safety and treatment effectiveness. The growing demand for personalized medicine is primarily driven by increasing recognition that traditional, uniform treatment models often fail to address variations in disease mechanisms and patient responses, thereby motivating clinicians and researchers to adopt precision-based approaches that deliver more predictable and meaningful outcomes. Necrobiosis lipoidica supports the rising demand for personalized medicine, as its heterogeneous presentation and variable treatment response patterns necessitate individualized therapeutic plans aligned with precision dermatology principles. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the USFDA approved 16 new personalized treatments for rare disease patients in 2023, a significant increase from 6 personalized treatments in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the necrobiosis lipoidica (NL) market.

Key Players In The Global Necrobiosis Lipodica (NL) Market

Major companies operating in the necrobiosis lipodica (nl) market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc, Novartis AG, Sanofi SA, GlaxoSmithKline plc, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Galderma Laboratories LP, Dr. Reddys Laboratories Ltd, Incyte Pharmaceuticals, Celltrion Healthcare Co Ltd, Almirall SA, Samsung Bioepis Co Ltd, HanAll Biopharma Co Ltd, AbbVie Inc, Amgen Inc, UCB Pharma SA, LEO Pharma AS, Bristol Myers Squibb Company, Roche Holding AG, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc

Regional Outlook

North America was the largest region in the necrobiosis lipoidica market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Necrobiosis Lipodica (NL) Market?

The necrobiosis lipoidica (NL) market consists of revenues earned by entities by provide services such as dermatology consultation, wound care services, and diagnosis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The necrobiosis lipoidica market includes sales of corticosteroids, immunomodulators, corticosteroid creams, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Necrobiosis Lipodica (NL) Market Report 2026?

The necrobiosis lipodica (nl) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the necrobiosis lipodica (nl) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.